HSP90 inhibitors and cancer: Prospects for use in targeted therapies

ZN Li, Y Luo - Oncology reports, 2022 - spandidos-publications.com
Heat shock protein 90 (HSP90) is a vital chaperone protein, regulating signaling pathways
and correcting misfolded proteins in cancer cells by interacting with oncogenic client …

[HTML][HTML] The disruption of protein− protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition

MA Serwetnyk, BSJ Blagg - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Abstract The 90-kiloDalton (kD) heat shock protein (Hsp90) is a ubiquitous, ATP-dependent
molecular chaperone whose primary function is to ensure the proper folding of several …

Cell surface thermal proteome profiling tracks perturbations and drug targets on the plasma membrane

M Kalxdorf, I Günthner, I Becher, N Kurzawa… - Nature …, 2021 - nature.com
Numerous drugs and endogenous ligands bind to cell surface receptors leading to
modulation of downstream signaling cascades and frequently to adaptation of the plasma …

[HTML][HTML] A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects

HJ Lee, HY Min, YS Yong, J Ann, CT Nguyen, MT La… - Theranostics, 2022 - ncbi.nlm.nih.gov
Rationale: The heat shock protein (Hsp) system plays important roles in cancer stem cell
(CSC) and non-CSC populations. However, limited efficacy due to drug resistance and …

HSP90 and co-chaperones: impact on tumor progression and prospects for molecular-targeted cancer therapy

A Jafari, M Rezaei-Tavirani… - Cancer …, 2020 - Taylor & Francis
Abstract Heat shock protein 90 (HSP90), a highly and unique chaperone, presents as a
double-edged sword. It plays an essential role in many physiological and pathological …

Impact of HDAC inhibitors on protein quality control systems: consequences for precision medicine in malignant disease

LAM Kulka, PV Fangmann, D Panfilova… - Frontiers in cell and …, 2020 - frontiersin.org
Lysine acetylation is one of the major posttranslational modifications (PTM) in human cells
and thus needs to be tightly regulated by the writers of this process, the histone acetyl …

[HTML][HTML] The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer

M Park, E Jung, JM Park, S Park, D Ko, J Seo, S Kim… - Theranostics, 2024 - ncbi.nlm.nih.gov
Rationale: Resistance to targeted therapies like trastuzumab remains a critical challenge for
HER2-positive breast cancer patients. Despite the progress of several N-terminal HSP90 …

Heat shock protein 90: biological functions, diseases, and therapeutic targets

H Wei, Y Zhang, Y Jia, X Chen, T Niu, A Chatterjee… - MedComm, 2024 - Wiley Online Library
Abstract Heat shock protein 90 (Hsp90) is a predominant member among Heat shock
proteins (HSPs), playing a central role in cellular protection and maintenance by aiding in …

Pharmacological basis and new insights of deguelin concerning its anticancer effects

ZY Lin, QZ Yun, L Wu, TW Zhang, TZ Yao - Pharmacological Research, 2021 - Elsevier
Deguelin is a rotenoid of the flavonoid family, which can be extracted from Lonchocarpus,
Derris, or Tephrosia. It possesses the inhibition of cancer cell proliferation by inducing …

Molecular insights into the heat shock proteins of the human parasitic blood fluke Schistosoma mansoni

NA Aguoru, RS Kirk, AJ Walker - Parasites & Vectors, 2022 - Springer
Abstract Background Heat shock proteins (HSPs) are evolutionarily conserved proteins,
produced by cells in response to hostile environmental conditions, that are vital to organism …